HealthEquity (HQY) Tops Q4 EPS by 5c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
HealthEquity, Inc (HQY) PT Raised to $98 at Oppenheimer
March 19, 2019 9:30 AM EDTOppenheimer analyst Mohan Naidu raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $98.00 (from $74.00) while maintaining a Outperform rating.
The analyst commented, "HQY wrapped up the year at the higher end of the pre-released FY19 numbers at revenue/adj. EPS of... More
